Literature DB >> 27405584

Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.

Simpa S Salami1, Eran Ben-Levi2, Oksana Yaskiv3, Baris Turkbey4, Robert Villani2, Ardeshir R Rastinehad5.   

Abstract

PURPOSE: To evaluate the performance of apparent diffusion coefficient (ADC) and lesion volume in potentially risk-stratifying patients with prostate cancer (PCa).
MATERIALS AND METHODS: Men with elevated prostate-specific antigen or abnormal digital rectal exam underwent a 3T multiparametric magnetic resonance imaging (mpMRI) with endorectal coil. ADC maps were calculated using b values of 0, 500, 1000, and 1500; additional images were obtained with b value of 2000. We prospectively enrolled 312 men with lesions suspicious for cancer (suspicion score 2-5) on mpMRI. MRI/ultrasound fusion-guided prostate biopsies were performed. Mean ADC of suspicious lesions were correlated against lesion volume, Gleason and D'Amico risk.
RESULTS: The cancer detection rate of fusion biopsy per lesion was 45.6% (206/452). Cancerous lesions were larger (median volume: 0.40 vs. 0.30 cm3 ; P = 0.016). The median ADC (×10-6 mm2 /sec) for lesions negative and positive for PCa were 984.5 and 666.5, respectively (P < 0.0001). The AUC of ADC in predicting PCa was 0.79. Larger lesions were associated with higher risk PCa (Gleason and D'Amico) and lower ADC (all P < 0.0001).
CONCLUSION: The mean ADC of suspicious lesions on mpMRI was inversely correlated, while lesion volume had a direct correlation with PCa detection. Future follow-up studies are needed to assess longitudinal cancer risks of suspicious mpMRI lesions. LEVEL OF EVIDENCE: 2 J. Magn. Reson. Imaging 2017;45:610-616.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  active surveillance; fusion biopsy; prostate cancer screening

Mesh:

Year:  2016        PMID: 27405584     DOI: 10.1002/jmri.25363

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

Review 1.  Diffusion and quantification of diffusion of prostate cancer.

Authors:  Yoshiko Ueno; Tsutomu Tamada; Keitaro Sofue; Takamichi Murakami
Journal:  Br J Radiol       Date:  2021-09-19       Impact factor: 3.039

2.  Reduced field-of-view and multi-shot DWI acquisition techniques: Prospective evaluation of image quality and distortion reduction in prostate cancer imaging.

Authors:  Edward M Lawrence; Yuxin Zhang; Jitka Starekova; Zihan Wang; Ali Pirasteh; Shane A Wells; Diego Hernando
Journal:  Magn Reson Imaging       Date:  2022-08-06       Impact factor: 3.130

Review 3.  MRI determined prostate volume and the incidence of prostate cancer on MRI-fusion biopsy: a systemic review of reported data for the last 20 years.

Authors:  Andrew S Knight; Pranav Sharma; Werner T W de Riese
Journal:  Int Urol Nephrol       Date:  2022-08-30       Impact factor: 2.266

4.  Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.

Authors:  Pietro Pepe; Davide D'Urso; Antonio Garufi; Giandomenico Priolo; Michele Pennisi; Giorgio Russo; Maria Gabriella Sabini; Lucia Maria Valastro; Antonio Galia; Filippo Fraggetta
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

5.  Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.

Authors:  Daniel R Ludwig; Tyler J Fraum; Kathryn J Fowler; Joseph E Ippolito
Journal:  Mo Med       Date:  2018 Mar-Apr

Review 6.  Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance.

Authors:  Zachary A Glaser; Jennifer B Gordetsky; Kristin K Porter; Sooryanarayana Varambally; Soroush Rais-Bahrami
Journal:  Front Oncol       Date:  2017-10-30       Impact factor: 6.244

Review 7.  Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification.

Authors:  Kyle H Gennaro; Kristin K Porter; Jennifer B Gordetsky; Samuel J Galgano; Soroush Rais-Bahrami
Journal:  Diagnostics (Basel)       Date:  2018-11-30

8.  MRI - ultrasound fusion guided biopsy of the prostate: lesion volume as a predictor of cancer in patients with repeat biopsies.

Authors:  Scott Alan Blaine; Haidar M Abdul-Muhsin; Nicholas J Jakob; Paul E Andrews; Robert G Ferrigni; Stephen S Cha; Ashkahn Golshani; Alvin C Silva; Akira Kawashima; Mitchell R Humphreys
Journal:  Indian J Urol       Date:  2019 Jul-Sep

Review 9.  MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence.

Authors:  Zachary A Glaser; Kristin K Porter; John V Thomas; Jennifer B Gordetsky; Soroush Rais-Bahrami
Journal:  Transl Androl Urol       Date:  2018-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.